Fidia S.p.A. (FRA:FIC0)
Germany · Delayed Price · Currency is EUR | Market Cap | 4.49M +9.5% |
| Revenue (ttm) | 30.56M +74.3% |
| Net Income | 1.04M |
| EPS | 0.00 |
| Shares Out | n/a |
| PE Ratio | 4.33 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Open | 0.0002 |
| Previous Close | 0.0002 |
| Day's Range | 0.0002 - 0.0002 |
| 52-Week Range | 0.0002 - 0.4400 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Sep 11, 2026 |
About Fidia
Fidia S.p.A., together with its subsidiaries, designs, manufactures, and sells high speed milling systems, numerical controls, milling heads, and software systems. The company offers HMS, a device for measuring and compensating geometric error on continuous or indexed bi-rotary heads and roto-tilting tables; TMSC, a device to measure length and diameter of the tool, as well as to check the shape; pushbutton panels; XPower digital drives for axis and spindle movement; and I/O Line input/output modules. It also provides software solutions include... [Read more]
Financial Performance
Financial StatementsNews
Aurobindo Pharma's subsidiary faces two US FDA observations after inspection
The United States Food and Drug Administration (US FDA) recently concluded an inspection at Auroactive Pharma Private Limited, a wholly owned subsidiary of Aurobindo Pharma, with two observations. The...
Viridian Wins FDA Approval For Lumvoa In Thyroid Eye Disease; Stock Up
(RTTNews) - Viridian Therapeutics, Inc. (VRDN) announced that the U.S. FDA has approved Lumvoa for the treatment of thyroid eye disease, marking the company's first commercial product and a major mile...
AbbVie (ABBV) Gains FDA Approval for Skyrizi in Children with Psoriasis
AbbVie (ABBV) Gains FDA Approval for Skyrizi in Children with Psoriasis
Lantheus (LNTH) Faces Setback with FDA Response on LNTH-2501
Lantheus (LNTH) Faces Setback with FDA Response on LNTH-2501
Viridian Therapeutics (VRDN) Receives FDA Approval for Lumvoa Treatment
Viridian Therapeutics (VRDN) Receives FDA Approval for Lumvoa Treatment
ABBV Gains FDA Approval for Skyrizi in Pediatric Psoriasis Treatment
ABBV Gains FDA Approval for Skyrizi in Pediatric Psoriasis Treatment
US FDA greenlights Viridian's thyroid eye disease drug
The U.S. Food and Drug Administration has approved Viridian Therapeutics' drug to treat patients with thyroid eye disease, the company said on Friday.
Viridian Therapeutics Announces U.S. FDA Approval and Launch of Lumvoa (veligrotug-vvze) for the Treatment of Thyroid Eye Disease
Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on discovering, developing, and commercializing potentially best-in-class medicines for autoimmune and rare diseases, today ...
Lantheus (LNTH) Faces FDA Response on LNTH-2501 Application
Lantheus (LNTH) Faces FDA Response on LNTH-2501 Application
US FDA declines Lantheus’ tumor imaging kit over third-party manufacturing issues
The U.S. Food and Drug Administration declined to approve Lantheus Holdings’ diagnostic imaging kit for types of cancer tumors citing unresolved manufacturing-related conditions at a third-party facil...
Swedish Orphan Biovitrum AB: Sobi receives complete response letter from FDA for NASP (nanoencapsulated sirolimus plus pegadricase)
STOCKHOLM, June 26, 2026 /PRNewswire/ --The FDA has requested additional data related to chemistry, manufacturing, and controls (CMC) and contract manufacturing facilities; no clinical safety or e...
FDA declines to approve Sobi's gout therapy on concerns over manufacturing
The U.S. Food and Drug Administration declined to approve Swedish drugmaker Sobi's therapy to treat uncontrolled gout, a common form of inflammatory arthritis, the company said on Friday.
457 held, ₹34.7 cr worth stock seized in 1 month of FDA crackdown
Maharashtra FDA crackdown (May 25–Jun 24, 2026): 904 raids statewide, ₹34.66 cr stock seized, 457 arrests, 322 units sealed, 42 vehicles seized.
Maharashtra FDA Shuts JJ Mahanagar Blood Bank Over Safety Violations
Maharashtra FDA halted JJ Mahanagar Blood Bank and sealed Maya Blood Centre after CDSCO inspection found serious blood safety and compliance violations.
Unicycive (UNCY) Advances Its Lead Candidate with FDA Review Timeline
Unicycive (UNCY) Advances Its Lead Candidate with FDA Review Timeline
British American Tobacco (BTI) Shares Rise on FDA Proposed Tobacco Regulation
British American Tobacco (BTI) Shares Rise on FDA Proposed Tobacco Regulation
Capricor Therapeutics (CAPR) Faces 12% Decline Ahead of FDA Advisory Meeting
Capricor Therapeutics (CAPR) Faces 12% Decline Ahead of FDA Advisory Meeting
FDA To Review Replimmune's Third BLA Submission For RP1 In Advanced Melanoma; Response By Aug 2026
(RTTNews) - Replimmune Group Inc. (REPL), a clinical-stage biotechnology company, on Friday announced the FDA acceptance of the biological license application (BLA) for RP-1 in combination with nivolu...
Lupin Gets Tentative FDA Nod For Enzalutamide Tablets
(RTTNews) - Lupin Limited (LUPIN) has received tentative approval from the U.S. FDA for its generic Enzalutamide Tablets, marking another step in the company's effort to expand its oncology portfolio ...
Capricor Therapeutics (CAPR) Seeks FDA Meeting for Cell Therapy Approval
Capricor Therapeutics (CAPR) Seeks FDA Meeting for Cell Therapy Approval
FDA Advisory Panel To Review Capricor's Deramiocel BLA In DMD
(RTTNews) - Capricor Therapeutics, Inc. (CAPR) announced that the U.S. Food and Drug Administration's Cellular, Tissue, and Gene Therapies Advisory Committee will meet to discuss the company's Biologi...
Peer To Peer Network: How PTOP's Synaptic Quant Works: AI Filters Market Noise, Identifies Catalysts, and Builds Complete Trade Plans for Retail Investors
AI-powered platform continuously analyzes breaking news, SEC filings, FDA announcements, earnings, options flow, dark pool activity, and thousands of additional market signals before generating AI ...
Weekly Buzz: IONS, MRK Get FDA Approvals; ACHV Gets CRL; ADCT Cuts Jobs; TECH Acquired
(RTTNews) - This week, the biotech sector delivered a mix of FDA and EU approvals, strategic reorganizations, layoff, acquisitions, and late-stage clinical readouts across oncology, metabolic disease,...
How PTOP's Synaptic Quant(TM) Works: AI Filters Market Noise, Identifies Catalysts, and Builds Complete Trade Plans for Retail Investors
AI-powered platform continuously analyzes breaking news, SEC filings, FDA announcements, earnings, options flow, dark pool activity, and thousands of additional market signals before generating AI con...
Replimune (REPL) Shares Decline After FDA Advisory Committee Announcement
Replimune (REPL) Shares Decline After FDA Advisory Committee Announcement